List of Argos Therapeutics patents

Patents where

Current Assignee

Name

Argos Therapeutics

Name	Description	Patent Applicant	Current Assignee	Patent Jurisdiction	Patent Number	Date of Patent
‌ US Patent 8431404 Apparatus for transfer of liquid for processing samples	Patent 8431404 was granted and assigned to Argos Therapeutics on April, 2013 by the United States Patent and Trademark Office.		Argos Therapeutics	United States Patent and Trademark Office	8431404	April 30, 2013
‌ US Patent 8030080 Systems and methods for processing samples in a closed container, and related devices	Patent 8030080 was granted and assigned to Argos Therapeutics on October, 2011 by the United States Patent and Trademark Office.		Argos Therapeutics	United States Patent and Trademark Office	8030080	October 4, 2011
‌ US Patent 8672879 Devices, systems and related methods suitable for delivery of a liquid medicament stored at cryogenic temperatures	Patent 8672879 was granted and assigned to Argos Therapeutics on March, 2014 by the United States Patent and Trademark Office.		Argos Therapeutics	United States Patent and Trademark Office	8672879	March 18, 2014
‌ US Patent 8236562 Method for producing ready to use, antigen-loaded or unloaded, cryoconserved mature dendritic cells	Patent 8236562 was granted and assigned to Argos Therapeutics on August, 2012 by the United States Patent and Trademark Office.		Argos Therapeutics	United States Patent and Trademark Office	8236562	August 7, 2012
‌ US Patent 9638707 Methods of processing samples	Patent 9638707 was granted and assigned to Argos Therapeutics on May, 2017 by the United States Patent and Trademark Office.	Argos Therapeutics	Argos Therapeutics	United States Patent and Trademark Office	9638707	May 2, 2017
‌ US Patent 9409178 Processing containers	Patent 9409178 was granted and assigned to Argos Therapeutics on August, 2016 by the United States Patent and Trademark Office.	Argos Therapeutics	Argos Therapeutics	United States Patent and Trademark Office	9409178	August 9, 2016
‌ US Patent 9527074 Processing containers	Patent 9527074 was granted and assigned to Argos Therapeutics on December, 2016 by the United States Patent and Trademark Office.	Argos Therapeutics	Argos Therapeutics	United States Patent and Trademark Office	9527074	December 27, 2016
‌ US Patent 8211701 Methods for processing samples in a closed container	Patent 8211701 was granted and assigned to Argos Therapeutics on July, 2012 by the United States Patent and Trademark Office.		Argos Therapeutics	United States Patent and Trademark Office	8211701	July 3, 2012
‌ US Patent 10022731 Centrifuge vessels with a center mound and an internal elongate tube suitable for live cell processing and associated systems and methods	Patent 10022731 was granted and assigned to Argos Therapeutics on July, 2018 by the United States Patent and Trademark Office.	Argos Therapeutics	Argos Therapeutics	United States Patent and Trademark Office	10022731	July 17, 2018
‌ US Patent RE46152 Dendritic cell compositions and methods	Patent RE46152 was granted and assigned to Argos Therapeutics on September, 2016 by the United States Patent and Trademark Office.	Argos Therapeutics	Argos Therapeutics	United States Patent and Trademark Office	RE46152	September 20, 2016
‌ US Patent 8153425 Dendritic cell compositions and methods	Patent 8153425 was granted and assigned to Argos Therapeutics on April, 2012 by the United States Patent and Trademark Office.		Argos Therapeutics	United States Patent and Trademark Office	8153425	April 10, 2012
‌ US Patent 7893200 Use of soluble forms of CD83 and nucleic acids encoding them for the treatment or prevention of diseases	Patent 7893200 was granted and assigned to Argos Therapeutics on February, 2011 by the United States Patent and Trademark Office.		Argos Therapeutics	United States Patent and Trademark Office	7893200	February 22, 2011
‌ US Patent 10184108 Mature dendritic cell compositions and methods for culturing same	Patent 10184108 was granted and assigned to Argos Therapeutics on January, 2019 by the United States Patent and Trademark Office.	Argos Therapeutics	Argos Therapeutics	United States Patent and Trademark Office	10184108	January 22, 2019
‌ US Patent 8221981 Primers and probes for the amplification and detection of HIV Gag, Rev and Nef polynucleotides	Patent 8221981 was granted and assigned to Argos Therapeutics on July, 2012 by the United States Patent and Trademark Office.		Argos Therapeutics	United States Patent and Trademark Office	8221981	July 17, 2012
‌ US Patent 9040303 Apparatus for measuring volume of a fluid	Patent 9040303 was granted and assigned to Argos Therapeutics on May, 2015 by the United States Patent and Trademark Office.	Argos Therapeutics	Argos Therapeutics	United States Patent and Trademark Office	9040303	May 26, 2015
‌ US Patent 9523077 Mature dendritic cell compositions and methods for culturing same	Patent 9523077 was granted and assigned to Argos Therapeutics on December, 2016 by the United States Patent and Trademark Office.	Argos Therapeutics	Argos Therapeutics	United States Patent and Trademark Office	9523077	December 20, 2016
‌ US Patent 8076134 CD4+CD25− T cells and Tr1-like regulatory T cells	Patent 8076134 was granted and assigned to Argos Therapeutics on December, 2011 by the United States Patent and Trademark Office.		Argos Therapeutics	United States Patent and Trademark Office	8076134	December 13, 2011
‌ US Patent 8222033 CD4	Patent 8222033 was granted and assigned to Argos Therapeutics on July, 2012 by the United States Patent and Trademark Office.		Argos Therapeutics	United States Patent and Trademark Office	8222033	July 17, 2012
‌ US Patent 9556455 Mature dendritic cell compositions and methods for culturing same	Patent 9556455 was granted and assigned to Argos Therapeutics on January, 2017 by the United States Patent and Trademark Office.	Argos Therapeutics	Argos Therapeutics	United States Patent and Trademark Office	9556455	January 31, 2017
‌ US Patent 8658771 Humanized antibodies against human interferon-alpha	Patent 8658771 was granted and assigned to Argos Therapeutics on February, 2014 by the United States Patent and Trademark Office.		Argos Therapeutics	United States Patent and Trademark Office	8658771	February 25, 2014
‌ US Patent 8574901 Cryoconserved mature dendritic cells	Patent 8574901 was granted and assigned to Argos Therapeutics on November, 2013 by the United States Patent and Trademark Office.		Argos Therapeutics	United States Patent and Trademark Office	8574901	November 5, 2013
‌ US Patent 9732140 Use of soluble forms of CD83 and nucleic acids encoding them for the treatment or prevention of diseases	Patent 9732140 was granted and assigned to Argos Therapeutics on August, 2017 by the United States Patent and Trademark Office.	Argos Therapeutics	Argos Therapeutics	United States Patent and Trademark Office	9732140	August 15, 2017
‌ US Patent 8361463 Humanized antibodies against human interferon-alpha	Patent 8361463 was granted and assigned to Argos Therapeutics on January, 2013 by the United States Patent and Trademark Office.		Argos Therapeutics	United States Patent and Trademark Office	8361463	January 29, 2013
‌ US Patent 10006901 CD4	Patent 10006901 was granted and assigned to Argos Therapeutics on June, 2018 by the United States Patent and Trademark Office.		Argos Therapeutics	United States Patent and Trademark Office	10006901	June 26, 2018
‌ US Patent 9085807 Strain-independent amplification of pathogens and vaccines thereto	Patent 9085807 was granted and assigned to Argos Therapeutics on July, 2015 by the United States Patent and Trademark Office.		Argos Therapeutics	United States Patent and Trademark Office	9085807	July 21, 2015

Results per page:

35 results

0 selected

35 results

0 selected